Especially for neuro-oncologists - Minimally important differences for the EORTC QLQ-C30 in glioma patients

Tito R. Mendoza

doi:10.1093/neuonc/noab124

Especially for neuro-oncologists - Minimally important differences for the EORTC QLQ-C30 in glioma patients

Tito R. Mendoza

Symptom Research CAO

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1222
Number of pages	1
Journal	Neuro-oncology
Volume	23
Issue number	8
DOIs	https://doi.org/10.1093/neuonc/noab124
State	Published - Aug 1 2021

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

Access to Document

10.1093/neuonc/noab124

Cite this

@article{b7f70acb539e4ffab9326b13c64a8c30,

title = "Especially for neuro-oncologists - Minimally important differences for the EORTC QLQ-C30 in glioma patients",

author = "Mendoza, {Tito R.}",

year = "2021",

month = aug,

day = "1",

doi = "10.1093/neuonc/noab124",

language = "English (US)",

volume = "23",

pages = "1222",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Especially for neuro-oncologists - Minimally important differences for the EORTC QLQ-C30 in glioma patients

AU - Mendoza, Tito R.

PY - 2021/8/1

Y1 - 2021/8/1

UR - http://www.scopus.com/inward/record.url?scp=85113322466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113322466&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noab124

DO - 10.1093/neuonc/noab124

M3 - Editorial

C2 - 34036365

AN - SCOPUS:85113322466

SN - 1522-8517

VL - 23

SP - 1222

JO - Neuro-oncology

JF - Neuro-oncology

IS - 8

ER -

Especially for neuro-oncologists - Minimally important differences for the EORTC QLQ-C30 in glioma patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this